ClearAdvance, LLC

Clear Labs is a genomics testing company specializing in fully automated next-generation sequencing (NGS) platforms for clinical diagnostics, food safety, and research applications. The company delivers end-to-end solutions integrating robotic automation, genomic sequencing, and bioinformatics software for pathogen detection, infectious disease surveillance, and oncology research. Clear Labs offers clinical diagnostic solutions for rapid bacterial and fungal identification from sterile specimens, whole genome sequencing for microbial surveillance, and food safety testing platforms (Clear Safety™) for Salmonella and Listeria detection and serotyping. Research-use-only platforms include Clear Dx® for oncology NGS workflows and Clear Ix™ for infectious disease sequencing. The company serves clinical laboratories, food safety operations, and research institutions, providing actionable molecular insights to reduce foodborne illness outbreaks and accelerate infectious disease and cancer genomics research.